Your browser doesn't support javascript.
loading
Leprosy post-exposure prophylaxis with single-dose rifampicin (LPEP): an international feasibility programme.
Richardus, Jan Hendrik; Tiwari, Anuj; Barth-Jaeggi, Tanja; Arif, Mohammad A; Banstola, Nand Lal; Baskota, Rabindra; Blaney, David; Blok, David J; Bonenberger, Marc; Budiawan, Teky; Cavaliero, Arielle; Gani, Zaahira; Greter, Helena; Ignotti, Eliane; Kamara, Deusdedit V; Kasang, Christa; Manglani, Pratap R; Mieras, Liesbeth; Njako, Blasdus F; Pakasi, Tiara; Pandey, Basu Dev; Saunderson, Paul; Singh, Rajbir; Smith, W Cairns S; Stäheli, René; Suriyarachchi, Nayani D; Tin Maung, Aye; Shwe, Tin; van Berkel, Jan; van Brakel, Wim H; Vander Plaetse, Bart; Virmond, Marcos; Wijesinghe, Millawage S D; Aerts, Ann; Steinmann, Peter.
  • Richardus JH; Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands. Electronic address: j.richardus@erasmusmc.nl.
  • Tiwari A; Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
  • Barth-Jaeggi T; Swiss Tropical and Public Health Institute, Basel, Switzerland; University of Basel, Basel, Switzerland.
  • Arif MA; NLR, New Delhi, India.
  • Banstola NL; NLR, Kathmandu, Nepal.
  • Baskota R; Ministry of Health and Population of Nepal, Kathmandu, Nepal.
  • Blaney D; Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Blok DJ; Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
  • Bonenberger M; FAIRMED, Bern, Switzerland.
  • Budiawan T; NLR, Jakarta, Indonesia.
  • Cavaliero A; Novartis Foundation, Basel, Switzerland.
  • Gani Z; Novartis Foundation, Basel, Switzerland.
  • Greter H; Swiss Tropical and Public Health Institute, Basel, Switzerland; University of Basel, Basel, Switzerland.
  • Ignotti E; Universidade do Estado de Mato Grosso, Cáceres, Brazil.
  • Kamara DV; National Tuberculosis and Leprosy Programme, Dodoma, Tanzania.
  • Kasang C; German Leprosy and Tuberculosis Relief Association, Würzburg, Germany.
  • Manglani PR; NLR, New Delhi, India.
  • Mieras L; NLR, Amsterdam, Netherlands.
  • Njako BF; German Leprosy and Tuberculosis Relief Association, Dar es Salaam, Tanzania.
  • Pakasi T; Ministry of Health of the Republic of Indonesia, Jakarta, Indonesia.
  • Pandey BD; Ministry of Health and Population of Nepal, Kathmandu, Nepal.
  • Saunderson P; American Leprosy Missions, Greenville, SC, USA.
  • Singh R; German Leprosy and Tuberculosis Relief Association, New Delhi, India.
  • Smith WCS; University of Aberdeen, Aberdeen, UK.
  • Stäheli R; FAIRMED, Bern, Switzerland.
  • Suriyarachchi ND; FAIRMED, Colombo, Sri Lanka.
  • Tin Maung A; American Leprosy Missions, Yangon, Myanmar.
  • Shwe T; American Leprosy Missions, Yangon, Myanmar.
  • van Berkel J; NLR, Amsterdam, Netherlands.
  • van Brakel WH; NLR, Amsterdam, Netherlands.
  • Vander Plaetse B; FAIRMED, Bern, Switzerland.
  • Virmond M; Instituto Lauro de Souza Lima & UNINOVE, Bauru, Brazil.
  • Wijesinghe MSD; Anti-Leprosy Campaign, Colombo, Sri Lanka.
  • Aerts A; Novartis Foundation, Basel, Switzerland.
  • Steinmann P; Swiss Tropical and Public Health Institute, Basel, Switzerland; University of Basel, Basel, Switzerland.
Lancet Glob Health ; 9(1): e81-e90, 2021 01.
Article en En | MEDLINE | ID: mdl-33129378
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Rifampin / Salud Pública / Profilaxis Posexposición / Leprostáticos / Lepra Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Rifampin / Salud Pública / Profilaxis Posexposición / Leprostáticos / Lepra Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article